Closing Bell: Nifty below 25,150, Sensex down 700 pts; pharma, FMCG buck the trend

Indian equity indices ended on a negative note with Nifty at 25,150 on July 11. At close, the Sensex was down 689.81 points or 0.83 percent at 82,500.47, and the Nifty was down 205.40 points or 0.81 percent at 25,149.85.

We wrap up today's edition of the Moneycontrol live market blog, and will be back Monday morning with all the latest updates and alerts. Please visit https://www.moneycontrol.com/markets/global-indices for all the global market action.

The Nifty continues to remain weak as the index slipped below the previous swing low on the hourly chart. Additionally, it has fallen below the 21 EMA on the daily timeframe.

Momentum also remains weak in the short term, with the RSI in a negative crossover. However, after the recent decline, the index has approached the support of the 200-hourly moving average.

A move above 25,150-25,160 in the initial trading hour could trigger a rally towards 25,250 and 25,400. On the downside, support is placed at 25,090 and 24,900.

While weak European market cues and negative US Dow Futures weighed on sentiment, the disappointing start to earnings season by software major TCS cautioned investors about the sluggish global demand scenario that led to heavy selling in IT, telecom, auto, realty and oil & gas stocks. While all eyes will be on the outcome of the trade negotiations with the US, markets could see increased volatility in the near term.

Today, the Indian stock market closed sharply lower with the Nifty 50 ending at 25,149, down about 0.81% or 205 points from the previous close. The BSE Sensex also fell by nearly 689 points, or 0.8%, closing around 82,500. The key reason for this negative closing was significant selling pressure in IT stocks following disappointing Q1 earnings results from major players like TCS, which weighed heavily on the Nifty IT index that tumbled around 1.7%.

Other sectors under pressure included autos, with the Nifty Auto index down about 1.77%, while defensive sectors such as Pharma and FMCG managed modest gains of around 0.55% each. Broader markets also saw declines.

The market sentiment was further dampened by concerns over global headwinds including tariff uncertainties related to US trade policies and subdued global economic outlook, which have raised worries about export growth and corporate earnings momentum. Profit booking and cautious investor stance ahead of upcoming earnings announcements also contributed to the decline.

Markets traded under pressure on Friday and lost over half a percent, dragged down by weak cues. The session began on a negative note following disappointing results from IT major TCS, which further worsened due to profit-taking in heavyweight stocks across other sectors.

On the sectoral front, all key indices ended in the red, except the defensives—FMCG and pharma. IT, auto, and realty were among the top losers. The broader indices also came under pressure, each declining by nearly a percent.

Sentiment remained subdued due to ongoing uncertainty around tariff-related issues and a weak start to the earnings season. As a result, the Nifty slipped below its first line of defense—the 20-day exponential moving average (20-DEMA)—disrupting the ongoing positive trend. We may now see a phase of consolidation in the index, with upcoming earnings keeping volatility high across sectors. In this environment, traders should exercise greater caution, focus on risk management, and be selective while identifying trading opportunities.

Rupee traded weak by 0.11% at 85.73 as capital market weakness, along with higher Gold and Silver prices and weak global cues, weighed on sentiment. The rise in tariffs from the US on Brazil and Canada has added uncertainty, and markets will remain cautious until constructive trade talks emerge.

Additionally, the dollar index has shown recovery, rising from 96.50 to 97.75, which has added pressure on emerging market currencies. Rupee is expected to trade in a range of 85.25 to 86.20.

The domestic market experienced a negative close due to a sober start to Q1 earnings season and a ramp-up in the tariff threat by the US to impose a 35% tariff on Canada. Investors may continue to be focused on quarterly earnings for a buy-on-dips strategy; however, in the near term, the current premium valuation and the global headwinds like low spending & tariff uncertainties may restrain new inflows. The IT index underperformed due to deferment in orders and new investments, which may impact FY26 earnings estimates.

Market slips for 2nd straight week, Sensex & Nifty down 1% each

IT has been biggest Nifty drag, HCL, TCS & Wipro amongst top losers

FMCG is top gaining index while IT & Capital market fall the most

Midcap falls in-line with benchmarks while Nifty Bank relatively outperforms

Nifty Midcap index is down 1.6% & Nifty Bank 0.5%

Indian rupee ended 16 paise lower at 85.80 per dollar on Friday versus previous close of 85.64.

At close, the Sensex was down 689.81 points or 0.83 percent at 82,500.47, and the Nifty was down 205.40 points or 0.81 percent at 25,149.85. About 1510 shares advanced, 2341 shares declined, and 150 shares unchanged.

Biggest Nifty losers were TCS, Bajaj Auto, M&M, Hero MotoCorp, Wipro, while gainers were HUL, SBI Life Insurance, Kotak Mahindra Bank, Axis Bank, IndusInd Bank.

BSE Midcap and smallcap indices shed 0.6 percent each.

Except FMCG (up 0.5 percent), pharma (up 0.7 percent), all other sectoral indices ended in the red with auto, IT, media, oil & gas, consumer durables, capital goods, realty, telecom down 1 percent each.

#1 Growth visibility for FY26 is still hazy

#2 Constant currency lower than the consensus estimate

#3 Company continues to expect FY26 to be better than FY25 for major markets

#4 Significant margin improvement in FY26 is unlikely

#5 Cut FY26-28 EPS estimates by 1-2 percent

#1 Growth visibility for FY26 is still hazy

#2 Constant currency lower than the consensus estimate

#3 Company continues to expect FY26 to be better than FY25 for major markets

#4 Significant margin improvement in FY26 is unlikely

#5 Cut FY26-28 EPS estimates by 1-2 percent

QIB – 0.63 times

NII - 1.7 times52

Retail – 1.04 times

Employee Reserved - 0.91

Overall – 1.03 times

#1 Another quarter of a miss on low expectations

#2 Company sounded constructive & hopeful of recovery driven by autos & media

#3 Stock outperformed most peers since April despite earnings downgrade cycle

Indian Rupee fell against the US Dollar by nearly 20 paise on weak domestic markets and risk off sentiments amid trade tariff uncertainty. Global market sentiments dented as US President imposed 35% tariffs on Canadian goods. US weekly unemployment claims fell to 227,000 vs forecast of 236,000 and 232,000 jobs in the week prior.

We expect Rupee to weaken on as the trade war continues to dent global risk sentiments. Uncertainty over trade tariffs and higher US Dollar index may also pressurise the Rupee. However, a weak tone in crude oil prices may support the Rupee at lower levels. USDINR spot price is expected to trade in a range of Rs 85.55 to Rs 86.25.

Indian rupee is trading 20 paise lower at 85.84 per dollar on Friday versus previous close of 85.64.

The Sensex was down 620.06 points or 0.75 percent at 82,570.22, and the Nifty was down 186.25 points or 0.73 percent at 25,169. About 1316 shares advanced, 2173 shares declined, and 116 shares unchanged.

Shares of Hindustan Unilever Ltd jumped nearly 4.5% after the company named Priya Nair as its new Managing Director and CEO, marking a historic moment as she becomes the first woman to lead the FMCG major in its 92-year history.

Investors are optimistic because Nair brings a strong track record of transforming underperforming segments into profit drivers. As Executive Director of Home Care from 2014 to 2020, she led a turnaround that lifted the segment’s EBIT margin by 570 basis points, from 13.1% in FY14 to 18.8% in FY20. This improvement played a key role in raising HUL’s overall EBIT margin from 15.0% to 22.3%. More recently, she headed Unilever’s €13.2 billion Beauty and Wellbeing business, managing powerhouse brands like Dove and Sunsilk, and driving a strategic shift towards premium categories.

Investors view this leadership change as a positive signal that blends continuity with fresh perspective and will help HUL navigate competition, accelerate digital transformation, and reinforce its leadership in India’s consumer goods space.

Adani Energy Solutions was quoting at Rs 880.00, down Rs 10.30, or 1.16 percent.

It has touched an intraday high of Rs 897.25 and an intraday low of Rs 876.75.

It was trading with volumes of 29,202 shares, compared to its five day average of 80,178 shares, a decrease of -63.58 percent.

In the previous trading session, the share closed down 0.02 percent or Rs 0.15 at Rs 890.30.

The share touched a 52-week high of Rs 1,347.90 and a 52-week low of Rs 588.25 on 01 August, 2024 and 27 November, 2024, respectively.

Currently, the stock is trading 34.71 percent below its 52-week high and 49.6 percent above its 52-week low.

Market capitalisation stands at Rs 105,712.87 crore.

NTPC was quoting at Rs 342.70, up Rs 1.40, or 0.41 percent. It has touched an intraday high of Rs 343.95 and an intraday low of Rs 340.

It was trading with volumes of 310,774 shares, compared to its five day average of 486,117 shares, a decrease of -36.07 percent.

In the previous trading session, the share closed down 0.73 percent or Rs 2.50 at Rs 341.30.

The share touched a 52-week high of Rs 448.30 and a 52-week low of Rs 292.70 on 30 September, 2024 and 17 February, 2025, respectively.

Currently, the stock is trading 23.56 percent below its 52-week high and 17.08 percent above its 52-week low.

Market capitalisation stands at Rs 332,304.75 crore.

Following recent regulatory action on a global participant, there’s been much speculation about what this means for retail activity in India’s capital markets. Around the same time, SEBI’s recent report on retail investor outcomes in the derivatives segment has rightly sparked conversations around investor protection and market behaviour.

I had stated that “with millions of active retail traders and deepening institutional activity, India’s market opportunity is structural, not cyclical…”

Over the past five years, we’ve seen something far more powerful than trading volumes. Retail participation in India is no longer fragile. It’s foundational. We’ve witnessed confidence, consistency, and conviction from a new generation of Indian investors across SIPs, ETFs, equity ownership, and market breadth.

This isn’t headline-driven momentum. It’s a structural shift. Retail India is not just trading. Retail India is owning and as that ownership compounds in value, they’re not stepping away. They’re staying in, trading and investing with purpose.

#1 Stock price has underperformed its large Indian peers over last 5 years

#2 Stock underperformance on de-rating as revenue conversion is slow

#3 Believe market will look at TCS growth ex-BSNL

#4 It can still deliver industry average growth in FY26

#5 Q1 revenue miss largely due to BSNL deal ramp-down

#6 Current valuations give comfort & see limited downside

Total - 1.04 times

QIB - 0.64 times

NII - 1.55 times

Retail - 1.04 times

Employee - 0.89 times

The Sensex was down 647.04 points or 0.78 percent at 82,543.24, and the Nifty was down 192.65 points or 0.76 percent at 25,162.60. About 1270 shares advanced, 2184 shares declined, and 118 shares unchanged.

NTPC was quoting at Rs 342.90, up Rs 1.60, or 0.47 percent.

It has touched an intraday high of Rs 343.95 and an intraday low of Rs 340.00.

It was trading with volumes of 295,409 shares, compared to its five day average of 486,117 shares, a decrease of -39.23 percent.

In the previous trading session, the share closed down 0.73 percent or Rs 2.50 at Rs 341.30.

The share touched a 52-week high of Rs 448.30 and a 52-week low of Rs 292.70 on 30 September, 2024 and 17 February, 2025, respectively.

Currently, the stock is trading 23.51 percent below its 52-week high and 17.15 percent above its 52-week low.

Market capitalisation stands at Rs 332,498.68 crore.

Eternal was quoting at Rs 264.40, up Rs 1.60, or 0.61 percent. It has touched an intraday high of Rs 264.75 and an intraday low of Rs 259.55.

It was trading with volumes of 4,438,892 shares, compared to its five day average of 2,357,194 shares, an increase of 88.31 percent.

In the previous trading session, the share closed down 0.64 percent or Rs 1.70 at Rs 262.80.

The share touched a 52-week high of Rs 304.50 and a 52-week low of Rs 189.60 on 09 December, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 13.17 percent below its 52-week high and 39.45 percent above its 52-week low.

Market capitalisation stands at Rs 255,155.27 crore.

Popular Vehicles & Services' 100% step down subsidiary Kuttukaran Cars has received a Letter of Intent (LOI) for setting up Ather facilities in Chennai, Tamil Nadu.

The facilities will be spread across two locations — one housing the Experience Centre, and the other accommodating the Service Centre and warehouse. The service centre will initially feature 5 bays, with capacity to service approximately 450 vehicles per month. Operations are expected to commence by the first week of September this year. Total investment for setting up these facilities is estimated at around Rs 75 Lakhs.

Tata Steel acquired 124,62,68,657 equity shares of face value USD 0.1005 each aggregating to USD 125.25 million (Rs 1,073.63 crore) in T Steel Holdings Pte. Ltd (TSHP’) Post this acquisition, TSHP will continue to be a wholly owned foreign subsidiary of the company.

QIB – 0.63 times

NII - 1.47 times

Retail – 0.97 times

Employee Reserved - 0.83

Overall – 0.98 times

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie have announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001. The drug was developed using IGI’s proprietary BEAT protein platform for oncology and autoimmune diseases.

Under the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. Subject to regulatory clearance, IGI will receive an upfront payment of $700 million and is eligible to receive up to $1.225 billion in development, regulatory, and commercial milestone payments, along with tiered, double-digit royalties on net sales. Ichnos Glenmark Innovation (IGI) is a strategic alliance between Glenmark Pharma and Ichnos Sciences Inc.

#1 Priya Nair is a Unilever Veteran with over 30 years of work experience

#2 Majority of 30 years term with company, she spent in India across various managerial roles

#3 Growth initiatives & drive towards improving volumes will benefit from her experience

Indian rupee is trading 20 paise lower at 85.84 per dollar versus previous close of 85.64.

Krystal Integrated Services has been awarded Rs 31.55 crore order for attendant manpower services of Maha Mumbai Metro Operation Corp. Ltd. (MMMOCL).

The Board of Directors of Mahindra Logistics at its meeting held on Friday, 11 July 2025, has  approved fund raising by way of offer and issuance of fully paid-up equity shares of the Company of face value of Rs 10 each for an amount not exceeding Rs 750 crore by way of a rights issue.

Mankind Pharma was quoting at Rs 2,599.90, up Rs 56.50, or 2.22 percent.

It has touched an intraday high of Rs 2,679 and an intraday low of Rs 2,550.

It was trading with volumes of 87,070 shares, compared to its five day average of 23,200 shares, an increase of 275.30 percent.

In the previous trading session, the share closed up 0.72 percent or Rs 18.10 at Rs 2,543.40.

The share touched a 52-week high of Rs 3,050 and a 52-week low of Rs 1,910.10 on 23 December, 2024 and 05 August, 2024, respectively.

Currently, the stock is trading 14.76 percent below its 52-week high and 36.11 percent above its 52-week low.

Market capitalisation stands at Rs 107,305.35 crore.

Zee Entertainment Enterprises failed to secure the required shareholder votes to raise funds by issuing warrants, blocking plans by the founding Goenka family to increase their stake in the broadcaster.

Only 59.5% of participating shareholders supported the resolution—falling short of the 75% majority required for approval, according to a report by Reuters.

To utilise its enhanced capacity and tap into growing global demand, the company is expanding its international presence by incorporating overseas subsidiaries in Poland, the United States of America, and Dubai, United Arab Emirates.

#1 Q1 was a miss at topline, largely led by BSNL, but also with a miss in international business

#2 Company seems to be struggling on profitability as well

#3 Demand commentary slightly weaker than expected

#1 Profit tanks 35.7% to Rs 246.9 crore Vs Rs 383.7 crore, YoY

#2 Revenue zooms 29% to Rs 1,947.6 crore Vs Rs 1,510.3 crore, YoY

#3 Impairment on financial instruments stands at Rs 362.6 crore Vs writeback at Rs (30.04) crore, YoY

ICICI Lombard General Insurance Company was quoting at Rs 2,011.00, up Rs 17.25, or 0.87 percent.

It has touched an intraday high of Rs 2,020.10 and an intraday low of Rs 1,991.25.

It was trading with volumes of 12,340 shares, compared to its five day average of 5,942 shares, an increase of 107.67 percent.

In the previous trading session, the share closed down 1.36 percent or Rs 27.45 at Rs 1,993.75.

The share touched a 52-week high of Rs 2,285.85 and a 52-week low of Rs 1,612.65 on 26 September, 2024 and 04 March, 2025, respectively.

Currently, the stock is trading 12.02 percent below its 52-week high and 24.7 percent above its 52-week low.

Market capitalisation stands at Rs 99,883.69 crore.

The Sensex was down 646.23 points or 0.78 percent at 82,544.05, and the Nifty was down 188.70 points or 0.74 percent at 25,166.55. About 1255 shares advanced, 2157 shares declined, and 125 shares unchanged.

QIB – 0.00 times

NII - 1.39 times

Retail – 0.90 times

Employee Reserved - 0.76

Overall – 0.75 times

Avenue Supermarts was quoting at Rs 4,081.40, down Rs 86.45, or 2.07 percent.

It has touched an intraday high of Rs 4,196.95 and an intraday low of Rs 4,057.90.

It was trading with volumes of 12,442 shares, compared to its five day average of 14,097 shares, a decrease of -11.74 percent.

In the previous trading session, the share closed down 0.52 percent or Rs 21.70 at Rs 4,167.85.

The share touched a 52-week high of Rs 5,484.00 and a 52-week low of Rs 3,337.10 on 24 September, 2024 and 03 March, 2025, respectively.

Currently, the stock is trading 25.58 percent below its 52-week high and 22.3 percent above its 52-week low.

Market capitalisation stands at Rs 265,590.19 crore.

Avenue Supermarts, Aditya Birla Money, Droneacharya Aerial Innovations, Elecon Engineering Company, Emerald Finance, Jagsonpal Finance & Leasing, Nath Bio-Genes (India), and Astonea Labs will announce quarterly earnings scorecard on July 11.

It has touched an intraday high of Rs 474.60 and an intraday low of Rs 446.85.

It was trading with volumes of 88,611 shares, compared to its five day average of 66,529 shares, an increase of 33.19 percent.

In the previous trading session, the share closed up 2.42 percent or Rs 10.60 at Rs 448.75.

The share touched a 52-week high of Rs 589.95 and a 52-week low of Rs 248.55 on 24 September, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 20.37 percent below its 52-week high and 89.02 percent above its 52-week low.

Bharti Airtel was quoting at Rs 1,921.05, down Rs 44.05, or 2.24 percent.

It has touched an intraday high of Rs 1,961.00 and an intraday low of Rs 1,917.45.

It was trading with volumes of 166,017 shares, compared to its five day average of 240,750 shares, a decrease of -31.04 percent.

In the previous trading session, the share closed down 2.62 percent or Rs 52.90 at Rs 1,965.10.

The share touched a 52-week high of Rs 2,045.50 and a 52-week low of Rs 1,421.55 on 02 July, 2025 and 12 July, 2024, respectively.

Currently, the stock is trading 6.08 percent below its 52-week high and 35.14 percent above its 52-week low.

Market capitalisation stands at Rs 1,114,243.05 crore.

#1 Company has cracked mega deal with AbbVie w.r.t ISB 2001

#2 Deal is largest licensing deal by any Indian pharma company

#3 Deal value is ahead of expectations

#1 Expect FY26 CC revenue to decline for overall business & stay flat for international business

#2 Should miss its target of 1 percent growth in international business

Add an NPV of Rs 470 per share, factoring in the upfront receipt of USD 700 mn as well as the receipt of USD 1.2 bn linked to development, regulatory, and commercial milestones payments.

Expect a 23% earnings CAGR over FY25-27, led by 10%/7%/12%/14% CAGR in the domestic formulation/US/EU/ROW segment and 200bp margin expansion

In addition to the significant commercial benefit from innovative R&D, GNP is actively strengthening its US generics pipeline in the respiratory and injectable segments.

Wipro was quoting at Rs 258.10, down Rs 7.00, or 2.64 percent. It has touched an intraday high of Rs 262.00 and an intraday low of Rs 257.80.

It was trading with volumes of 417,648 shares, compared to its five day average of 248,580 shares, an increase of 68.01 percent.

In the previous trading session, the share closed down 0.97 percent or Rs 2.60 at Rs 265.10.

The share touched a 52-week high of Rs 324.55 and a 52-week low of Rs 225.05 on 23 January, 2025 and 07 April, 2025, respectively.

Currently, the stock is trading 20.47 percent below its 52-week high and 14.69 percent above its 52-week low.

Market capitalisation stands at Rs 270,557.99 crore.

The company is going to announce its Q1FY26 earnings on 17 July, 2025.

The Board of Directors of Dodla Dairy approved acquisition of 100% issued and paid-up share capital of HR Food Processing (OSAM).

This strategic acquisition aligns with the company's expansion strategy and will enhance its market reach in the eastern region of India.

Dodla Dairy shall enter into the SPAs and other transaction documents / agreements with the existing promoters and shareholders of the Target Company for acquisition of 100% of issued and paid share capital.

The objective of acquisition is to enter new geographical markets, the business carried on by the Target Company is similar business carried on by Dodla Dairy Limited.

The Board has appointed Richa Arora as an Independent Director of the company.

JB Chemicals and Pharmaceuticals was quoting at Rs 1,612.90, up Rs 0.35, or 0.02 percent.

It has touched an intraday high of Rs 1,622.50 and an intraday low of Rs 1,605.00.

It was trading with volumes of 856 shares, compared to its five day average of 166,235 shares, a decrease of -99.49 percent.

In the previous trading session, the share closed down 1.24 percent or Rs 20.25 at Rs 1,612.55.

The share touched a 52-week high of Rs 2,029.00 and a 52-week low of Rs 1,303.00 on 16 August, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 20.51 percent below its 52-week high and 23.78 percent above its 52-week low.

Market capitalisation stands at Rs 25,170.74 crore.

The Board of Directors will meet on July 15 to consider a proposal for raising funds via the issuance of equity shares or other eligible securities.

Centrum Capital was quoting at Rs 37.00, down Rs 0.21, or 0.56 percent. It has touched an intraday high of Rs 39.00 and an intraday low of Rs 36.51.

It was trading with volumes of 8,457 shares, compared to its five day average of 74,267 shares, a decrease of -88.61 percent.

In the previous trading session, the share closed up 4.99 percent or Rs 1.77 at Rs 37.21.

The share touched a 52-week high of Rs 43.69 and a 52-week low of Rs 22.41 on 30 July, 2024 and 07 April, 2025, respectively.

Currently, the stock is trading 15.31 percent below its 52-week high and 65.1 percent above its 52-week low.

Market capitalisation stands at Rs 1,539.32 crore.

The Board has approved the re-appointment of Ashwin Moodliar as Managing Director of the company for a period of two years, effective February 1, 2026. His current term ends on January 31, 2026.

nternational Travel House was quoting at Rs 508.00, down Rs 18.10, or 3.44 percent. It has touched an intraday high of Rs 527.00 and an intraday low of Rs 504.00.

It was trading with volumes of 15,290 shares, compared to its five day average of 8,095 shares, an increase of 88.89 percent.

In the previous trading session, the share closed up 1.22 percent or Rs 6.35 at Rs 526.10.

The share touched a 52-week high of Rs 750.00 and a 52-week low of Rs 380.00 on 16 October, 2024 and 03 March, 2025, respectively.

Currently, the stock is trading 32.27 percent below its 52-week high and 33.68 percent above its 52-week low.

Market capitalisation stands at Rs 406.12 crore.

Shareholders have approved the re-appointment and remuneration of Pankaj Shah as Managing Director & CEO of the company for a term of three consecutive years, effective August 1, 2025.

The Sensex was down 625.51 points or 0.75 percent at 82,564.77, and the Nifty was down 182.00 points or 0.72 percent at 25,173.25. About 1201 shares advanced, 2041 shares declined, and 143 shares unchanged.

#1 High credit cost & opex pose medium-term RoA challenges

#2 Expect RoA of 1 percent by FY27

#3 Sector tailwinds to support growth, NIM to remain stable

#4 Risk-reward seems neutral with limited upside potential

RPP-BCC IV has been received letter of acceptance for a new work order Retrofitting work for providing water supply through FHTC as per JIM Guidelines in 202 Main Habitations and 355 other Habitations of Ajmer Rural, Arain and Silora Blocks of District Ajmer from Bisalpur dam System under Ial Ieevan Mission with Operation and Maintenance for 10 years for the Contract value 365.85 Crores(including Gst).

RPP Infra Projects Limited is the Lead Member in the Joint Venture named M/s RPP-BCC IV, holding a 51% participating share in the said Ioint Venture.

The Tata Power Company was quoting at Rs 396.95, down Rs 2.85, or 0.71 percent. It has touched an intraday high of Rs 401.50 and an intraday low of Rs 396.50.

It was trading with volumes of 37,912 shares, compared to its five day average of 224,212 shares, a decrease of -83.09 percent.

In the previous trading session, the share closed down 0.16 percent or Rs 0.65 at Rs 399.80.

The share touched a 52-week high of Rs 494.85 and a 52-week low of Rs 326.25 on 27 September, 2024 and 17 February, 2025, respectively.

Currently, the stock is trading 19.78 percent below its 52-week high and 21.67 percent above its 52-week low.

Market capitalisation stands at Rs 126,839.00 crore.

Shantanu Srivastava has resigned as Chief Risk Officer of the company, effective October 6, 2025, due to personal reasons.

SBI Cards & Payment Services was quoting at Rs 919.60, down Rs 16.40, or 1.75 percent. It has touched an intraday high of Rs 932.00 and an intraday low of Rs 919.60.

It was trading with volumes of 9,481 shares, compared to its five day average of 132,322 shares, a decrease of -92.83 percent.

In the previous trading session, the share closed up 0.18 percent or Rs 1.65 at Rs 936.00.

The share touched a 52-week high of Rs 1,023.05 and a 52-week low of Rs 660.00 on 10 June, 2025 and 29 October, 2024, respectively.

Currently, the stock is trading 10.11 percent below its 52-week high and 39.33 percent above its 52-week low.

Market capitalisation stands at Rs 87,502.49 crore.

The company has transferred its liquified petroleum gas (LPG) terminal, with cryogenic static storage capacity of 48,000 MT at Pipavav, to Aegis Vopak Terminals via a slump sale on a going concern basis for Rs 428.4 crore.

Aegis Logistics was quoting at Rs 745.95, down Rs 2.10, or 0.28 percent. It has touched an intraday high of Rs 759.35 and an intraday low of Rs 742.50.

It was trading with volumes of 15,394 shares, compared to its five day average of 23,600 shares, a decrease of -34.77 percent.

In the previous trading session, the share closed up 0.67 percent or Rs 4.95 at Rs 748.05.

The share touched a 52-week high of Rs 1,035.70 and a 52-week low of Rs 610.50 on 08 January, 2025 and 28 January, 2025, respectively.

Currently, the stock is trading 27.98 percent below its 52-week high and 22.19 percent above its 52-week low.

Market capitalisation stands at Rs 26,182.85 crore.

Indian rupee is trading 22 paise lower at 85.86 per dollar versus previous close of 85.64.

#1 Profit surges 27.9% to Rs 93.9 crore Vs Rs 73.4 crore, YoY

#2 Revenue grows 15.3% to Rs 274 crore Vs Rs 237.6 crore, YoY

JMJ Fintech was quoting at Rs 20.57, down Rs 17.28, or 45.65 percent on the BSE.

It has touched a 52-week low of Rs 19.19.

It has touched an intraday high of Rs 20.59 and an intraday low of Rs 19.19.

Market capitalisation stands at Rs 26.33 crore.

The Sensex was down 332.74 points or 0.40 percent at 82,857.54, and the Nifty was down 89.80 points or 0.35 percent at 25,265.45. About 1611 shares advanced, 1428 shares declined, and 156 shares unchanged.

Mankind Pharma was quoting at Rs 2,664.00, up Rs 120.60, or 4.74 percent. It has touched an intraday high of Rs 2,666.00 and an intraday low of Rs 2,550.

It was trading with volumes of 31,636 shares, compared to its five day average of 23,200 shares, an increase of 36.36 percent.

In the previous trading session, the share closed up 0.72 percent or Rs 18.10 at Rs 2,543.40.

The share touched a 52-week high of Rs 3,050.00 and a 52-week low of Rs 1,910.10 on 23 December, 2024 and 05 August, 2024, respectively.

Currently, the stock is trading 12.66 percent below its 52-week high and 39.47 percent above its 52-week low.

Market capitalisation stands at Rs 109,950.94 crore.